Enable Biosciences is a South San Francisco-based diagnostics company. We develop ultrasensitive immunoassays that permit early detection and treatment of autoimmune and infectious diseases.
| Website | http://www.enablebiosciences.com |
| Revenue | $11 million |
| Employees | 18 (15 on RocketReach) |
| Address | 510 Myrtle Ave STE 101, South San Francisco, California 94080, US |
| Phone | +1 650-240-3105 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+10 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Life Science |
| Competitors | Roche, Thermo Fisher Scientific, The Janssen Pharmaceutical Companies of Johnson & Johnson, Genentech, Merck Group, Agilent Technologies, Illumina, Bio-Rad Laboratories, abcam, SAB Biotherapeutics , Inc. +46 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies |
Looking for a particular Enable Biosciences employee's phone or email?
The Enable Biosciences annual revenue was $11 million in 2026.
David Seftel is the CEO and Chief Medical Officer of Enable Biosciences.
15 people are employed at Enable Biosciences.
Enable Biosciences is based in South San Francisco, California.
The NAICS codes for Enable Biosciences are [541, 5417, 54, 541714, 54171].
The SIC codes for Enable Biosciences are [873, 87].